ITCI Annual Cash & Cash Equivalents
$147.77 M
-$848.00 K-0.57%
31 December 2023
Summary:
As of January 21, 2025, ITCI annual cash & cash equivalents is $147.77 million, with the most recent change of -$848.00 thousand (-0.57%) on December 31, 2023. During the last 3 years, it has risen by +$87.72 million (+146.09%). ITCI annual cash & cash equivalents is now -0.57% below its all-time high of $148.62 million, reached on December 31, 2022.ITCI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Quarterly Cash And Cash Equivalents
$464.31 M
-$228.99 M-33.03%
30 September 2024
Summary:
As of January 21, 2025, ITCI quarterly cash and cash equivalents is $464.31 million, with the most recent change of -$228.99 million (-33.03%) on September 30, 2024. Over the past year, it has increased by +$364.91 million (+367.11%). ITCI quarterly cash and cash equivalents is now -33.03% below its all-time high of $693.31 million, reached on June 30, 2024.ITCI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.6% | +367.1% |
| 3 y3 years | +146.1% | +367.1% |
| 5 y5 years | +168.9% | +367.1% |
ITCI Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.6% | +60.0% | -33.0% | +513.1% |
| 5 y | 5-year | -0.6% | +146.1% | -33.0% | +673.3% |
| alltime | all time | -0.6% | >+9999.0% | -33.0% |
Intra-Cellular Therapies Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $464.31 M(-33.0%) |
| June 2024 | - | $693.31 M(+395.9%) |
| Mar 2024 | - | $139.82 M(-5.4%) |
| Dec 2023 | $147.77 M(-0.6%) | $147.77 M(+48.7%) |
| Sept 2023 | - | $99.40 M(-30.1%) |
| June 2023 | - | $142.26 M(+87.9%) |
| Mar 2023 | - | $75.73 M(-49.0%) |
| Dec 2022 | $148.62 M(+60.9%) | $148.62 M(+9.8%) |
| Sept 2022 | - | $135.36 M(+75.3%) |
| June 2022 | - | $77.23 M(-40.3%) |
| Mar 2022 | - | $129.29 M(+40.0%) |
| Dec 2021 | $92.36 M(+53.8%) | $92.36 M(-13.0%) |
| Sept 2021 | - | $106.13 M(-12.3%) |
| June 2021 | - | $121.03 M(-6.9%) |
| Mar 2021 | - | $129.98 M(+116.5%) |
| Dec 2020 | $60.05 M(-44.2%) | $60.05 M(-80.1%) |
| Sept 2020 | - | $300.99 M(+132.8%) |
| June 2020 | - | $129.29 M(-28.0%) |
| Mar 2020 | - | $179.59 M(+66.9%) |
| Dec 2019 | $107.64 M(+95.9%) | $107.64 M(+5.4%) |
| Sept 2019 | - | $102.16 M(+11.3%) |
| June 2019 | - | $91.76 M(+43.2%) |
| Mar 2019 | - | $64.09 M(+16.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $54.95 M(+45.4%) | $54.95 M(-21.3%) |
| Sept 2018 | - | $69.78 M(+0.0%) |
| June 2018 | - | $69.77 M(-6.3%) |
| Mar 2018 | - | $74.42 M(+96.9%) |
| Dec 2017 | $37.79 M(-22.3%) | $37.79 M(-27.8%) |
| Sept 2017 | - | $52.34 M(+76.9%) |
| June 2017 | - | $29.59 M(+25.4%) |
| Mar 2017 | - | $23.60 M(-51.5%) |
| Dec 2016 | $48.64 M(+3.1%) | $48.64 M(-75.7%) |
| Sept 2016 | - | $200.39 M(+285.6%) |
| June 2016 | - | $51.97 M(+39.6%) |
| Mar 2016 | - | $37.24 M(-21.0%) |
| Dec 2015 | $47.16 M(-23.1%) | $47.16 M(-85.8%) |
| Sept 2015 | - | $332.83 M(+366.0%) |
| June 2015 | - | $71.42 M(-29.1%) |
| Mar 2015 | - | $100.80 M(+64.4%) |
| Dec 2014 | $61.33 M(+74.5%) | $61.33 M(-11.0%) |
| Sept 2014 | - | $68.92 M(-24.4%) |
| June 2014 | - | $91.14 M(-36.5%) |
| Mar 2014 | - | $143.62 M(+308.6%) |
| Dec 2013 | $35.15 M(>+9900.0%) | $35.15 M(-20.2%) |
| Sept 2013 | - | $44.07 M(>+9900.0%) |
| June 2013 | - | $0.00 |
| Mar 2013 | $4100.00 | - |
FAQ
- What is Intra-Cellular Therapies annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual cash & cash equivalents year-on-year change?
- What is Intra-Cellular Therapies quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly cash and cash equivalents year-on-year change?
What is Intra-Cellular Therapies annual cash & cash equivalents?
The current annual cash & cash equivalents of ITCI is $147.77 M
What is the all time high annual cash & cash equivalents for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual cash & cash equivalents is $148.62 M
What is Intra-Cellular Therapies annual cash & cash equivalents year-on-year change?
Over the past year, ITCI annual cash & cash equivalents has changed by -$848.00 K (-0.57%)
What is Intra-Cellular Therapies quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ITCI is $464.31 M
What is the all time high quarterly cash and cash equivalents for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly cash and cash equivalents is $693.31 M
What is Intra-Cellular Therapies quarterly cash and cash equivalents year-on-year change?
Over the past year, ITCI quarterly cash and cash equivalents has changed by +$364.91 M (+367.11%)